Recent advances in techniques for the isolation and analysis of single-cells are enabling researchers to explore cellular heterogeneity in normal and diseased tissues at an unprecedented scale.
The Oxford Single Cell Biology Consortium (OSCBC) was established in July 2014 via the UK Clinical Research Capabilities and Technologies Initiative. The OSCBC includes over 30 interactive research groups across the Oxford Biomedical Institutes and Science Departments, working on a wide range of different areas.
The OSCBC also houses a number of state-of-the-art technology platforms housed in two single-cell facilities based at the MRC Weatherall Institute of Molecular Medicine and the Oxford Genomics Centre at the Wellcome Centre for Human Genetics.
OSCBC researchers meet regularly to share data and research ideas and the OSCBC steering group meets regularly to oversee current activities and new developments in the Consortium.
Steering group members:
- Single Cell Facility Manager, MRC WIMM
- Dr Rory Bowden, WHG
- Prof Enzo Cerundolo, MRC WIMM
- Prof Doug Higgs (Chair), MRC WIMM
- Prof Rob Klose, Department of Biochemistry
- Prof Xin Lu, Nuffield Department of Medicine
- Dr Adam Mead, MRC WIMM
- Dr Stephen Sansom, Kennedy Institute of Reumatology
Director: Prof Doug Higgs
MRC WIMM Facility Scientific Lead: Dr Adam Mead
MRC WIMM Facility Manager: Dr Maria Greco
WHG Facility Scientific Lead: Dr Rory Bowden
WHG Projects Enquiries: HTG contact